Available inInjectable
Dosage18mg/3ml
ManufacturerNovo Nordisk
Available inInjectable
Dosage2mg/3ml, 2mg/1.5ml, 4mg/3ml, 8mg/3ml
ManufacturerNovo Nordisk
As Canada's leading online pharmacy, we make sure you always have your meds on time. Use our app and website to fill prescriptions, order refills, and consult with our pharmacists. Take control of your health from home or on the go!
We won't bore you with the details, but Health Canada requires you to sign in.
By proceeding you agree to our Terms of Use & Privacy Policy
The recommended starting dose of Victoza (Liraglutide) is 0.6 mg daily injected subcutaneously (under the skin) on your stomach area (abdomen), upper thigh, or upper arm, exactly as instructed by your doctor or diabetes educator. It can be injected at any time of the day, without regard to meals. After one week, your doctor may increase the dose to 1.2 mg once daily. If needed, your doctor may increase the dose again in one week to 1.8 mg once daily. Do not change your dose unless your doctor has told you to do so.
If you are also using insulin, each medication should be injected separately.
Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is important to take Victoza (Liraglutide) exactly as prescribed by your doctor. If you miss a dose, inject your dose on the next day as usual. Do not inject a double dose or increase your dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Victoza (Liraglutide) should be clear and colourless. Do not use Victoza (Liraglutide) if you notice particles or anything unusual in the appearance of the solution.
Store Victoza (Liraglutide) in the refrigerator, do not allow it to freeze, and keep it out of the reach of children. After the first use of the pen, Victoza (Liraglutide) can be stored at room temperature or in the refrigerator for up to 30 days. To protect Victoza (Liraglutide) from light, always keep the pen cap on when you are not using it. Always store Victoza (Liraglutide) without a needle attached to prevent contamination, infection, and leakage.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Each 1 mL of clear, colourless solution contains 1.34 mg of Ozempic (Semaglutide). Nonmedicianl ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injections.
There are 2 forms of the pre-filled, multi-dose, disposable pen. One pen delivers doses of 0.25 mg and 0.5 mg Ozempic (Semaglutide), while the other pen delivers 1 mg doses only.
Each pen contains 2 mg of Ozempic (Semaglutide).
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Victoza (Liraglutide). If you are concerned about side effects, discuss the risks and benefits of Victoza (Liraglutide) with your doctor.
The following side effects have been reported by at least 1% of people taking Victoza (Liraglutide). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of these side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Victoza (Liraglutide).
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Ozempic (Semaglutide). If you are concerned about side effects, discuss the risks and benefits of Ozempic (Semaglutide) with your doctor.
The following side effects have been reported by at least 1% of people taking Ozempic (Semaglutide). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Ozempic (Semaglutide).
Each mL of clear, colourless solution contains 6 mg of Victoza (Liraglutide). Nonmedicinal ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injection.
Each 1 mL of clear, colourless solution contains 1.34 mg of Ozempic (Semaglutide). Nonmedicianl ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injections.
There are 2 forms of the pre-filled, multi-dose, disposable pen. One pen delivers doses of 0.25 mg and 0.5 mg Ozempic (Semaglutide), while the other pen delivers 1 mg doses only.
Each pen contains 2 mg of Ozempic (Semaglutide).
Do not use Victoza (Liraglutide) if you:
Do not take Ozempic (Semaglutide) if you:
There may be an interaction between Victoza (Liraglutide) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Victoza (Liraglutide). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
There may be an interaction between Ozempic (Semaglutide) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Ozempic (Semaglutide). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
All material copyright MediResource Inc. 1996-2021. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Source: www.medbroadcast.com/drug/getdrug/Ozempic
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Victoza (Liraglutide).
Diabetes identification: It is important to either wear a bracelet (or necklace) or carry a card indicating you have diabetes and are taking medication to manage your blood glucose levels.
Heart problems: Victoza (Liraglutide) may increase heart rate and may affect how electrical impulses travel through the heart muscle. If you have heart disease (e.g., recent Heart Attack, Angina, heart failure) or an abnormal heart rhythm (e.g., heart block or fast heart rate), discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Intestinal problems: The safety and effectiveness of using Victoza (Liraglutide) for people with inflammatory bowel disease (e.g., Crohn's Disease, Ulcerative Colitis) or who have slowed movement through the intestinal tract due to diabetes have not been established. If you have digestive system problems, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Kidney function: The safety and effectiveness of using Victoza (Liraglutide) for people with reduced kidney function has not been studied. Ensure that you are drinking enough water to prevent dehydration if you experience nausea or vomiting with Victoza (Liraglutide). If you have reduced kidney function or Kidney Disease, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Liver function: The safety and effectiveness of using Victoza (Liraglutide) for people with reduced liver function have not been studied. If you have reduced liver function or liver disease, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Low blood glucose (hypoglycemia): People who use Victoza (Liraglutide) and are also taking a sulfonylurea (e.g., Glyburide, Gliclazide) to control high blood sugar are more at risk of experiencing hypoglycemia (low blood sugar). If you experience symptoms of hypoglycemia such as a cold sweat, nervousness or shakiness, fast heartbeat, headache, hunger, confusion, lightheadedness, weakness, and numbness or tingling of the tongue or lips, contact your doctor. Your doctor may need to adjust the dose of your medication(s).
Pancreatitis (inflammation of the pancreas): Victoza (Liraglutide) may cause pancreatitis. If you experience symptoms of pancreatitis such as severe and persistent abdominal pain that may move to the back with or without vomiting, contact your doctor immediately. If you have previously had pancreatitis, discuss with your doctor how Victoza (Liraglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Victoza (Liraglutide), and whether any special monitoring is needed.
Risk of thyroid cancer: In rare cases, people have developed thyroid cancer while using Victoza (Liraglutide). People with a personal or family history of thyroid cancer or people who have multiple endocrine neoplasia syndrome type 2 (a disease where people have tumours in more than one gland in their body) should not use Victoza (Liraglutide). If you develop a lump in your neck or experience difficulty swallowing or breathing, or persistent hoarseness, contact your doctor as soon as possible.
Pregnancy: Victoza (Liraglutide) has not been studied for use by pregnant women and should not be used during pregnancy. If you become pregnant while using Victoza (Liraglutide), contact your doctor immediately.
Breast-feeding: It is not known if Victoza (Liraglutide) passes into breast milk. If you are a breast-feeding mother and are taking Victoza (Liraglutide), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Victoza (Liraglutide) have not been established for children younger than 10 years of age.
Seniors: Seniors may be more likely to experience side effects associated with Victoza (Liraglutide).
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Ozempic (Semaglutide).
Diabetes identification: It is important to either wear a bracelet (or necklace) or carry a card indicating you have diabetes and are taking medication to manage your blood glucose levels.
Heart problems: Ozempic (Semaglutide) may increase heart rate and may affect how electrical impulses travel through the heart muscle. If you have heart disease or an abnormal heart rhythm (e.g., heart block or fast heart rate), discuss with your doctor how Ozempic (Semaglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ozempic (Semaglutide), and whether any special monitoring is needed.
Kidney function: Ozempic (Semaglutide) may cause decreased kidney function, kidney failure or worsening chronic kidney failure. If you have reduced kidney function or Kidney Disease, discuss with your doctor how Ozempic (Semaglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ozempic (Semaglutide), and whether any special monitoring is needed.
Low blood glucose (hypoglycemia): People who use Ozempic (Semaglutide) and are also taking a sulfonylurea (e.g., glyburide, Gliclazide) or insulin to control high blood sugar are more at risk of experiencing hypoglycemia (low blood sugar). If you experience symptoms of hypoglycemia such as a cold sweat, nervousness or shakiness, fast heartbeat, headache, hunger, confusion, lightheadedness, weakness, and numbness or tingling of the tongue or lips, contact your doctor. Your doctor may need to adjust the dose of your medication(s).
Pancreatitis (inflammation of the pancreas): Ozempic (Semaglutide) can cause pancreatitis. If you experience symptoms of pancreatitis such as severe and persistent abdominal pain that may move to the back with or without vomiting, contact your doctor immediately. If you have previously had pancreatitis, discuss with your doctor how Ozempic (Semaglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ozempic (Semaglutide), and whether any special monitoring is needed.
Risk of thyroid cancer: In rare cases, people have developed thyroid cancer while using medications similar to Ozempic (Semaglutide). People with a personal or family history of thyroid cancer or people who have multiple endocrine neoplasia syndrome type 2 (a disease where people have tumours in more than one gland in their body) should not use Ozempic (Semaglutide). If you develop difficulty swallowing or breathing, hoarseness or notice a mass developing in your neck, contact your doctor as soon as possible.
Pregnancy: Ozempic (Semaglutide) should not be used during pregnancy. If you become pregnant while using Ozempic (Semaglutide), contact your doctor immediately.
Breast-feeding: It is not known if Ozempic (Semaglutide) passes into breast milk. If you are a breast-feeding mother and are taking Ozempic (Semaglutide), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Ozempic (Semaglutide) have not been established for children.
Online pharmacies delivering to:
Unit 6 - 6375 Dixie Rd, Mississauga
ON, L5T 2E7
Pocketpills is licensed by Ontario College of PharmacistsAccreditation #: 307234
Pharmacy Manager: Jasneet Dulai
Other locations
© 2018-2025 Pocketpills Pharmacy
By using this website, you accept our Terms of Service and Privacy Policy.
